Site icon pharmaceutical daily

Veeva Announces Fiscal 2020 Fourth Quarter and Fiscal Year 2020 Results

Fiscal Year 2020 Total Revenues of $1,104.1M, up 28% Year-over-year; Q4 Total Revenues of $311.5M, up 34% Year-over-year

Fiscal Year 2020 Subscription Services Revenues of $896.3M, up 29% Year-over-year; Q4 Subscription Services Revenues of $254.1M, up 33% Year-over-year

PLEASANTON, Calif.–(BUSINESS WIRE)–#LifeSciences–Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal fourth quarter ended January 31, 2020. All results in the current period and guidance reflect the impact from our recently acquired businesses.

“The past year was an exceptional one for Veeva. We focused on customer success and accelerated our pace of innovation in established and new markets,” said CEO Peter Gassner. “We have set ourselves up well from a product, operating model, and team perspective to execute on the major opportunities ahead.”

Fiscal 2020 Fourth Quarter Results:

Fiscal Year 2020 Results:

“Q4 capped off a year of consistent outperformance driven by strong execution in Commercial Cloud and Vault,” said CFO Tim Cabral. “Our leadership is fueled by a track record of identifying and bringing great cloud solutions to large, underserved markets and a relentless focus on customer success.”

Recent Highlights:

Financial Outlook:

Veeva is providing guidance for its fiscal first quarter ending April 30, 2020 as follows:

Veeva is providing guidance for its fiscal year ending January 31, 2021 as follows:

Conference Call Information:

What:

Veeva’s Fiscal 2020 Fourth Quarter and Full Year Results Conference Call

When:

Tuesday, March 3, 2020

Time:

1:30 p.m. PT (4:30 p.m. ET)

Live Call:

1-833-235-5654, domestic

 

1-647-689-4160, international

 

Conference ID 477 5017

Webcast:

ir.veeva.com

___________

(1) This press release uses non-GAAP financial metrics that are adjusted for the impact of various GAAP items. See the section titled “Non-GAAP Financial Measures” and the tables entitled “Reconciliation of GAAP to Non-GAAP Financial Measures” below for details.

(2) We calculate our annual subscription services revenue retention rate for a particular fiscal year by dividing (i) annualized subscription revenue as of the last day of that fiscal year from those customers that were also customers as of the last day of the prior fiscal year by (ii) the annualized subscription revenue from all customers as of the last day of the prior fiscal year. Annualized subscription revenue is calculated by multiplying the daily subscription revenue recognized on the last day of the fiscal year by 365. This calculation includes the impact on our revenues from customer non-renewals, deployments of additional users or decreases in users, deployments of additional solutions or discontinued use of solutions by our customers, and price changes for our solutions.

(3) The combined customer counts for Veeva Commercial Cloud and Veeva Vault exceed the total customer count in each year because some customers subscribe to products in both areas. Veeva Commercial Cloud customers are those customers that have at least one of the following products: Veeva CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Oncology Link, and Veeva Network Customer Master. Veeva Vault customers are those customers that have at least one Vault product. Note that net new customers from Crossix and Physicians World are included in Veeva Commercial Cloud.

(4) Veeva is not able, at this time, to provide GAAP targets for operating income and fully diluted net income per share for the first fiscal quarter ending April 30, 2020 or fiscal year ending January 31, 2021 because of the difficulty of estimating certain items excluded from non-GAAP operating income and non-GAAP fully diluted net income per share that cannot be reasonably predicted, such as charges related to stock-based compensation expense. The effect of these excluded items may be significant.

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.

Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor our investor relations website in addition to following our press releases, SEC filings and public conference calls and webcasts.

Forward-looking Statements

This release contains forward-looking statements, including the quotations from management, the statements in “Financial Outlook,” and other statements regarding Veeva’s future performance, market growth, the benefits from the use of Veeva’s solutions, our strategies, and general business conditions. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates and expectations and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including (i) breaches in our security measures or unauthorized access to our customers’ data; (ii) our expectation that the future growth rate of our revenues will decline; (iii) fluctuation of our results, which may make period-to-period comparisons less meaningful; (iv) competitive factors, including but not limited to pricing pressures, consolidation among our competitors, entry of new competitors, the launch of new products and marketing initiatives by our existing competitors, and difficulty securing rights to access, host or integrate with complementary third party products or data used by our customers; (v) the rate of adoption of our newer solutions and the results of our efforts to sustain or expand the use and adoption of our more established applications, like Veeva CRM; (vi) our ability to integrate Crossix Systems Inc. and Physicians World LLC into our business and achieve the expected benefits of the acquisitions; (vii) loss of one or more customers, particularly any of our large customers; (viii) system unavailability, system performance problems, or loss of data due to disruptions or other problems with our computing infrastructure; (ix) our ability to attract and retain highly skilled employees and manage our growth effectively; (x) failure to sustain the level of profitability we have achieved in the past as our costs increase; (xi) adverse changes in the life sciences industry, including as a result of customer mergers; (xii) adverse changes in economic, regulatory, or market conditions, including with respect to natural disasters or actual or threatened public health emergencies; (xiii) a decline in new subscriptions that may not be immediately reflected in our operating results due to the ratable recognition of our subscription revenue; and (xiv) pending, threatened, or future legal proceedings and related expenses.

Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s filing on Form 10-Q for the period ended October 31, 2019. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

VEEVA SYSTEMS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

 

January 31,

2020

 

January 31,

2019

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

476,733

 

 

$

550,971

 

Short-term investments

610,015

 

 

539,190

 

Accounts receivable, net

389,690

 

 

303,465

 

Unbilled accounts receivable

32,817

 

 

18,122

 

Prepaid expenses and other current assets

21,869

 

 

21,666

 

Total current assets

1,531,124

 

 

1,433,414

 

Property and equipment, net(5)

54,752

 

 

54,966

 

Deferred costs, net

35,585

 

 

30,869

 

Lease right-of-use assets(5)

49,132

 

 

 

Goodwill

438,529

 

 

95,804

 

Intangible assets, net

134,601

 

 

24,521

 

Deferred income taxes, noncurrent

11,870

 

 

5,938

 

Other long-term assets

16,184

 

 

8,254

 

Total assets

$

2,271,777

 

 

$

1,653,766

 

 

 

 

 

Liabilities and stockholders equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

19,420

 

 

$

9,110

 

Accrued compensation and benefits

25,619

 

 

15,324

 

Accrued expenses and other current liabilities

21,620

 

 

16,145

 

Income tax payable

5,613

 

 

4,086

 

Deferred revenue

468,887

 

 

356,357

 

Lease liabilities(5)

10,013

 

 

 

Total current liabilities

551,172

 

 

401,022

 

Deferred income taxes, noncurrent

2,417

 

 

6,095

 

Lease liabilities, noncurrent(5)

44,815

 

 

 

Other long-term liabilities

7,779

 

 

8,900

 

Total liabilities

606,183

 

 

416,017

 

Stockholders’ equity:

 

 

 

Class A common stock

1

 

 

1

 

Class B common stock

 

 

 

Additional paid-in capital

745,475

 

 

617,623

 

Accumulated other comprehensive income

460

 

 

928

 

Retained earnings(5)

919,658

 

 

619,197

 

Total stockholders’ equity

1,665,594

 

 

1,237,749

 

Total liabilities and stockholders equity

$

2,271,777

 

 

$

1,653,766

 

_______________________

(5)

 

The Company adopted ASU 2016-02, “Leases” (Topic 842) using the modified retrospective method as of February 1, 2019 and elected the transition option that allows the Company not to restate the comparative periods in their financial statements in the year of adoption.

VEEVA SYSTEMS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

 

 

Three months ended

January 31,

 

Fiscal year ended

January 31,

 

2020

 

2019

 

2020

 

2019

Revenues:

 

 

 

 

 

 

 

Subscription services

$

254,107

 

 

$

190,658

 

 

$

896,294

 

 

$

694,467

 

Professional services and other

57,401

 

 

41,665

 

 

207,787

 

 

167,743

 

Total revenues

311,508

 

 

232,323

 

 

1,104,081

 

 

862,210

 

Cost of revenues(6):

 

 

 

 

 

 

 

Cost of subscription services

42,506

 

 

29,615

 

 

136,328

 

 

117,009

 

Cost of professional services and other

51,813

 

 

34,911

 

 

167,041

 

 

128,272

 

Total cost of revenues

94,319

 

 

64,526

 

 

303,369

 

 

245,281

 

Gross profit

217,189

 

 

167,797

 

 

800,712

 

 

616,929

 

Operating expenses(6):

 

 

 

 

 

 

 

Research and development

61,201

 

 

42,759

 

 

209,895

 

 

158,783

 

Sales and marketing

59,369

 

 

38,561

 

 

190,331

 

 

148,867

 

General and administrative

36,225

 

 

23,479

 

 

114,267

 

 

86,413

 

Total operating expenses

156,795

 

 

104,799

 

 

514,493

 

 

394,063

 

Operating income

60,394

 

 

62,998

 

 

286,219

 

 

222,866

 

Other income, net

4,844

 

 

5,690

 

 

27,478

 

 

15,777

 

Income before income taxes

65,238

 

 

68,688

 

 

313,697

 

 

238,643

 

Provision for income taxes

(944

)

 

(2,463

)

 

12,579

 

 

8,811

 

Net income

$

66,182

 

 

$

71,151

 

 

$

301,118

 

 

$

229,832

 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

Basic

$

0.44

 

 

$

0.49

 

 

$

2.03

 

 

$

1.59

 

Diluted

$

0.42

 

 

$

0.45

 

 

$

1.90

 

 

$

1.47

 

 

 

 

 

 

 

 

 

Weighted-average shares used to compute net income per share:

 

 

 

 

 

 

 

Basic

148,773

 

 

145,667

 

 

147,796

 

 

144,244

 

Diluted

158,792

 

 

156,935

 

 

158,296

 

 

156,117

 

Other comprehensive income:

 

 

 

 

 

 

 

Net change in unrealized gains on available-for- sale investments

$

212

 

 

$

714

 

 

$

2,388

 

 

$

1,409

 

Net change in cumulative foreign currency translation loss

74

 

 

1,453

 

 

(2,857

)

 

(2,081

)

Comprehensive income

$

66,468

 

 

$

73,318

 

 

$

300,649

 

 

$

229,160

 

_______________________

 

 

 

 

(6) Includes stock-based compensation as follows:

 

Cost of revenues:

 

 

 

 

 

 

 

Cost of subscription services

$

1,110

 

 

$

387

 

 

$

2,638

 

 

$

1,553

 

Cost of professional services and other

5,257

 

 

2,808

 

 

17,518

 

 

10,575

 

Research and development

11,269

 

 

5,856

 

 

37,001

 

 

22,138

 

Sales and marketing

8,330

 

 

4,638

 

 

27,537

 

 

18,381

 

General and administrative

11,493

 

 

6,089

 

 

31,212

 

 

23,778

 

Total stock-based compensation

$

37,459

 

 

$

19,778

 

 

$

115,906

 

 

$

76,425

 

VEEVA SYSTEMS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

Three months ended

January 31,

 

Fiscal year ended

January 31,

 

2020

 

2019

 

2020

 

2019

Cash flows from operating activities

 

 

 

 

 

 

 

Net income

$

66,182

 

 

$

71,151

 

 

$

301,118

 

 

$

229,832

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

11,183

 

 

3,954

 

 

27,825

 

 

14,071

 

Accretion of discount on short-term investments

(278

)

 

(1,051

)

 

(3,274

)

 

(2,431

)

Stock-based compensation

37,459

 

 

19,778

 

 

115,906

 

 

76,425

 

Amortization of deferred costs

5,997

 

 

4,681

 

 

20,521

 

 

18,378

 

Deferred income taxes

(8,434

)

 

(10,733

)

 

(6,663

)

 

(8,091

)

(Gain) loss on foreign currency from mark-to-market derivative

(8

)

 

5

 

 

(120

)

 

(177

)

Bad debt expense (recovery)

286

 

 

(64

)

 

244

 

 

198

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

(242,164

)

 

(213,348

)

 

(55,531

)

 

(78,995

)

Unbilled accounts receivable

(1,778

)

 

1,867

 

 

(14,555

)

 

(4,774

)

Deferred costs

(11,709

)

 

(7,515

)

 

(25,237

)

 

(18,941

)

Income taxes payable

(3,727

)

 

112

 

 

1,131

 

 

637

 

Other current and long-term assets

(4,213

)

 

(1,035

)

 

(2,700

)

 

(10,562

)

Accounts payable

1,597

 

 

(1,698

)

 

2,813

 

 

1,822

 

Accrued expenses and other current liabilities

(15,461

)

 

4,661

 

 

(15,230

)

 

963

 

Deferred revenue

203,390

 

 

160,032

 

 

97,753

 

 

89,416

 

Lease liabilities

(2,337

)

 

 

 

(7,480

)

 

 

Other long-term liabilities

3,124

 

 

1,436

 

 

854

 

 

3,056

 

Net cash provided by operating activities

39,109

 

 

31,873

 

 

437,375

 

 

310,827

 

Cash flows from investing activities

 

 

 

 

 

 

 

Purchases of short-term investments

(123,734

)

 

(137,309

)

 

(752,518

)

 

(726,379

)

Maturities and sales of short-term investments

116,693

 

 

184,382

 

 

688,091

 

 

632,329

 

Property and equipment

54

 

 

(2,882

)

 

(3,113

)

 

(8,440

)

Acquisitions, net of cash and restricted cash acquired

(448,162

)

 

 

 

(448,162

)

 

 

Capitalized internal-use software development costs

(147

)

 

(370

)

 

(1,208

)

 

(1,379

)

Net cash provided by (used in) investing activities

(455,296

)

 

43,821

 

 

(516,910

)

 

(103,869

)

Cash flows from financing activities

 

 

 

 

 

 

 

Reduction of lease liabilities – finance leases

(255

)

 

 

 

(984

)

 

 

Proceeds from exercise of common stock options

2,376

 

 

6,182

 

 

10,994

 

 

25,910

 

Net cash provided by financing activities

2,121

 

 

6,182

 

 

10,010

 

 

25,910

 

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

75

 

 

1,453

 

 

(2,856

)

 

(2,077

)

Net change in cash, cash equivalents, and restricted cash

(413,991

)

 

83,329

 

 

(72,381

)

 

230,791

 

Cash, cash equivalents, and restricted cash at beginning of period

893,788

 

 

468,849

 

 

552,178

 

 

321,387

 

Cash, cash equivalents, and restricted cash at end of period

$

479,797

 

$

552,178

$

479,797

$

552,178

Non-GAAP Financial Measures

In Veeva’s public disclosures, Veeva has provided non-GAAP measures, which it defines as financial information that has not been prepared in accordance with generally accepted accounting principles in the United States, or GAAP. In addition to its GAAP measures, Veeva uses these non-GAAP financial measures internally for budgeting and resource allocation purposes and in analyzing its financial results. For the reasons set forth below, Veeva believes that excluding the following items provides information that is helpful in understanding its operating results, evaluating its future prospects, comparing its financial results across accounting periods, and comparing its financial results to its peers, many of which provide similar non-GAAP financial measures.

Contacts

Investor Relations Contact:
Rick Lund

Veeva Systems Inc.

925-271-9816

ir@veeva.com

Media Contact:
Roger Villareal

Veeva Systems Inc.

925-264-8885

pr@veeva.com

Read full story here

Exit mobile version